Variant report
Variant | esv3473999 |
---|---|
Chromosome Location | chr6:54662522-54665922 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6926885 | chr6:54662538-54662539 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs116963060 | chr6:54662559-54662560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577165382 | chr6:54662562-54662563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545784720 | chr6:54662596-54662597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562775914 | chr6:54662633-54662634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576458676 | chr6:54662636-54662637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541979444 | chr6:54662637-54662638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561886841 | chr6:54662646-54662647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560612104 | chr6:54662669-54662670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10456688 | chr6:54662693-54662694 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs6904875 | chr6:54662706-54662707 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs533305407 | chr6:54662707-54662708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190175979 | chr6:54662748-54662749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564306581 | chr6:54662786-54662787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140855099 | chr6:54662806-54662807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375451637 | chr6:54662851-54662852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568270481 | chr6:54662880-54662881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534125434 | chr6:54662889-54662890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553988230 | chr6:54662942-54662943 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6919743 | chr6:54662944-54662945 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs539771137 | chr6:54662945-54662946 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116428955 | chr6:54662953-54662954 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576372589 | chr6:54662956-54662957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542265486 | chr6:54662967-54662968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181838788 | chr6:54663013-54663014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200778909 | chr6:54663020-54663021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540366536 | chr6:54663052-54663053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6920088 | chr6:54663064-54663065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187373487 | chr6:54663067-54663068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372251054 | chr6:54663070-54663071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35188104 | chr6:54663085-54663086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs397707110 | chr6:54663086-54663087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs147883326 | chr6:54663142-54663143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140421137 | chr6:54663164-54663165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7452200 | chr6:54663168-54663169 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs528885057 | chr6:54663182-54663183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549012383 | chr6:54663189-54663190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565430229 | chr6:54663190-54663191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548890895 | chr6:54663255-54663256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190873932 | chr6:54663281-54663282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568843931 | chr6:54663294-54663295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181932045 | chr6:54663393-54663394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570732096 | chr6:54663433-54663434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540088683 | chr6:54663525-54663526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372392930 | chr6:54663541-54663542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142312873 | chr6:54663561-54663562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148124532 | chr6:54663569-54663570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs67328469 | chr6:54663570-54663571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs6149593 | chr6:54663572-54663573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375754224 | chr6:54663573-54663574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:54653200-54667800 | Weak transcription | Placenta Amnion | Placenta Amnion |
2 | chr6:54662800-54663000 | Enhancers | Fetal Intestine Small | intestine |
3 | chr6:54663000-54667800 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr6:54664800-54665000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:54664800-54666600 | Active TSS | Skeletal Muscle Male | skeletal muscle |
6 | chr6:54665200-54666200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr6:54665600-54666800 | Active TSS | Skeletal Muscle Female | skeletal muscle |